Clinical Commissioning Groups (CCGs) from across London have expressed interest in trialling and adopting digital self-management platform HealthSuite from Ampersand Health as a new care pathway that reduces budget strains and increases patient empowerment.
Interest in mobile health from patients, healthcare providers and carers has never been greater. However, mHealth is still in an incredibly nascent stage and the potential for smartphones, connected medical accessories and apps continues to be hugely unexploited across the healthcare industry.
Digital therapeutics are about moving the needle in science. They don’t just give you lifestyle tips, they connect you to your doctor. They help take self-management to the next level by allowing patients to take ownership of their conditions and, together with their clinicians, forge new pathways to improved health outcomes and better quality of life.
Ampersand has been recognised as a leading HealthTech Innovator in the 2017 Global Digital Health 100! GDH 100 is one of the HealthTech industries foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered.